Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avalon GloboCare (ALBT) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Avalon GloboCare (ALBT) over the last 10 years, with Q3 2025 value amounting to $333931.0.

  • Avalon GloboCare's Cash & Equivalents fell 6739.58% to $333931.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $333931.0, marking a year-over-year decrease of 6739.58%. This contributed to the annual value of $2.9 million for FY2024, which is 90080.9% up from last year.
  • As of Q3 2025, Avalon GloboCare's Cash & Equivalents stood at $333931.0, which was down 6739.58% from $201532.0 recorded in Q2 2025.
  • In the past 5 years, Avalon GloboCare's Cash & Equivalents registered a high of $3.9 million during Q3 2022, and its lowest value of $200572.0 during Q2 2024.
  • For the 5-year period, Avalon GloboCare's Cash & Equivalents averaged around $1.0 million, with its median value being $685304.0 (2021).
  • Its Cash & Equivalents has fluctuated over the past 5 years, first plummeted by 9132.11% in 2023, then surged by 90080.9% in 2024.
  • Over the past 5 years, Avalon GloboCare's Cash & Equivalents (Quarter) stood at $807538.0 in 2021, then surged by 146.54% to $2.0 million in 2022, then crashed by 85.66% to $285400.0 in 2023, then skyrocketed by 900.81% to $2.9 million in 2024, then plummeted by 88.31% to $333931.0 in 2025.
  • Its Cash & Equivalents stands at $333931.0 for Q3 2025, versus $201532.0 for Q2 2025 and $1.4 million for Q1 2025.